These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33691552)

  • 1. Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications.
    Khoubnasabjafari M; Mogaddam MRA; Rahimpour E; Soleymani J; Saei AA; Jouyban A
    Crit Rev Anal Chem; 2022; 52(7):1461-1487. PubMed ID: 33691552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.
    Chou H; Godbeer L; Allsworth M; Boyle B; Ball ML
    Metabolomics; 2024 Jul; 20(4):72. PubMed ID: 38977623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breathomics from exhaled volatile organic compounds in pediatric asthma.
    Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New perspectives on 'Breathomics': metabolomic profiling of non-volatile organic compounds in exhaled breath using DI-FT-ICR-MS.
    Malik M; Demetrowitsch T; Schwarz K; Kunze T
    Commun Biol; 2024 Mar; 7(1):258. PubMed ID: 38431745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicine.
    Sukul P; Schubert JK; Zanaty K; Trefz P; Sinha A; Kamysek S; Miekisch W
    Sci Rep; 2020 Aug; 10(1):14109. PubMed ID: 32839494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.
    Ibrahim W; Carr L; Cordell R; Wilde MJ; Salman D; Monks PS; Thomas P; Brightling CE; Siddiqui S; Greening NJ
    Thorax; 2021 May; 76(5):514-521. PubMed ID: 33414240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled breath analysis by electronic nose in respiratory diseases.
    Scarlata S; Pennazza G; Santonico M; Pedone C; Antonelli Incalzi R
    Expert Rev Mol Diagn; 2015; 15(7):933-56. PubMed ID: 25959642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Breathomics Database.
    Kuo TC; Tan CE; Wang SY; Lin OA; Su BH; Hsu MT; Lin J; Cheng YY; Chen CS; Yang YC; Chen KH; Lin SW; Ho CC; Kuo CH; Tseng YJ
    Database (Oxford); 2020 Jan; 2020():. PubMed ID: 31976536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The versatile use of exhaled volatile organic compounds in human health and disease.
    Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
    J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breathomics Detect the Cardiovascular Disease: Delusion or Dilution of the Metabolomic Signature.
    Marzoog B
    Curr Cardiol Rev; 2024; 20(4):e020224226647. PubMed ID: 38318837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled Molecular Fingerprinting in Diagnosis and Monitoring: Validating Volatile Promises.
    Boots AW; Bos LD; van der Schee MP; van Schooten FJ; Sterk PJ
    Trends Mol Med; 2015 Oct; 21(10):633-644. PubMed ID: 26432020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breath Biomarkers in Diagnostic Applications.
    Pham YL; Beauchamp J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taking your breath away: metabolomics breathes life in to personalized medicine.
    Rattray NJ; Hamrang Z; Trivedi DK; Goodacre R; Fowler SJ
    Trends Biotechnol; 2014 Oct; 32(10):538-48. PubMed ID: 25179940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driving progress in exhaled breath biomarkers: Breath Biopsy Conference 2019.
    Lawson J; Boyle B; Beauchamp J
    J Breath Res; 2020 Jul; 14(3):030202. PubMed ID: 32662449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease.
    Santini G; Mores N; Penas A; Capuano R; Mondino C; Trové A; Macagno F; Zini G; Cattani P; Martinelli E; Motta A; Macis G; Ciabattoni G; Montuschi P
    Curr Top Med Chem; 2016; 16(14):1610-30. PubMed ID: 26693732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current breathomics--a review on data pre-processing techniques and machine learning in metabolomics breath analysis.
    Smolinska A; Hauschild AC; Fijten RR; Dallinga JW; Baumbach J; van Schooten FJ
    J Breath Res; 2014 Jun; 8(2):027105. PubMed ID: 24713999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatile Organic Compounds in Human Breath.
    Karunagaran M; Ramani P; Gheena S; Abilasha R; Hannah R
    Indian J Dent Res; 2022; 33(1):100-104. PubMed ID: 35946254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clinical Breathomics Dataset.
    Kuo PH; Jhong YC; Kuo TC; Hsu YT; Kuo CH; Tseng YJ
    Sci Data; 2024 Feb; 11(1):203. PubMed ID: 38355591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.